Compare uniQure N.V. Ordinary Shares (QURE) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Williams Companies Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Williams Companies Inc trades at $73.41 (market cap $89.05B). The key difference: Williams Companies Inc is far larger — about 61.4× uniQure N.V. Ordinary Shares's market cap, and Williams Companies Inc pays a 2.88% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Williams Companies Inc for 58 Days on average.
| QURE | WMB | |
|---|---|---|
Market Cap | $1.45B | $89.05B |
Volume | 3,323,243 | 10,633,946 |
Sector | Health | Energy |
52-Week High | $70.59 | $79.40 |
52-Week Low | $9.03 | $56.51 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $707.46M | $119.67B |
Dividend Yield | — | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WMB trades at $74.57, up 0.54% with strong bullish technical indicators and analyst consensus. The stock shows robust fundamentals with $11.95B revenue, 25.18% net margin, and consistent dividend payments. Recent earnings beat expectations in Q1 2026, while technical analysis indicates bullish momentum with support at $72-73 and resistance at $75-76 levels.
WMB presents a compelling investment case with strong analyst support (79% buy rating) and $87.08 price target upside. The company benefits from stable fee-based revenues and AI-driven natural gas demand growth. Key risks include energy market volatility and high debt levels, but the resilient midstream model and dividend growth trajectory support long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
